LPL Financial LLC lifted its stake in shares of MetLife (NYSE:MET) by 12.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 174,479 shares of the financial services provider’s stock after acquiring an additional 18,830 shares during the period. LPL Financial LLC’s holdings in MetLife were worth $8,822,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of MET. First Dallas Securities Inc. purchased a new stake in MetLife in the 4th quarter valued at about $111,000. Ffcm LLC raised its holdings in MetLife by 2,020.8% in the 3rd quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock valued at $119,000 after buying an additional 2,142 shares during the period. Sandy Spring Bank raised its holdings in MetLife by 495.2% in the 4th quarter. Sandy Spring Bank now owns 2,375 shares of the financial services provider’s stock valued at $120,000 after buying an additional 1,976 shares during the period. Avestar Capital LLC purchased a new stake in MetLife in the 4th quarter valued at about $135,000. Finally, Valeo Financial Advisors LLC purchased a new stake in MetLife in the 3rd quarter valued at about $151,000. Institutional investors and hedge funds own 77.64% of the company’s stock.
Several analysts recently issued reports on the stock. Zacks Investment Research lowered shares of MetLife from a “hold” rating to a “sell” rating in a report on Tuesday. Wells Fargo restated a “buy” rating and issued a $60.00 price objective on shares of MetLife in a report on Friday, March 16th. ValuEngine upgraded shares of MetLife from a “buy” rating to a “strong-buy” rating in a report on Wednesday, March 7th. UBS restated a “neutral” rating and issued a $51.00 price objective (down from $52.00) on shares of MetLife in a report on Friday, March 2nd. Finally, Keefe, Bruyette & Woods restated a “buy” rating and issued a $56.00 price objective on shares of MetLife in a report on Friday, February 23rd. Two analysts have rated the stock with a sell rating, nine have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $57.90.
MetLife stock opened at $47.22 on Thursday. The firm has a market capitalization of $48,929.55, a PE ratio of 9.52, a price-to-earnings-growth ratio of 0.96 and a beta of 1.28. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15. MetLife has a 52-week low of $43.38 and a 52-week high of $55.91.
MetLife (NYSE:MET) last released its earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.41). The firm had revenue of $15.79 billion during the quarter, compared to analyst estimates of $15.89 billion. MetLife had a net margin of 5.69% and a return on equity of 8.59%. During the same period in the prior year, the firm earned $1.28 earnings per share. equities research analysts anticipate that MetLife will post 4.93 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 3.39%. The ex-dividend date of this dividend was Friday, February 2nd. MetLife’s dividend payout ratio is currently 46.92%.
MetLife Company Profile
MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife (NYSE:MET).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.